The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2014

Filed:

Mar. 10, 2009
Applicants:

Juliette Gimenez, Caluire et Cuire, FR;

Cecile Montgiraud, Lyons, FR;

Francois Mallet, Villeurbanne, FR;

Inventors:

Juliette Gimenez, Caluire et Cuire, FR;

Cecile Montgiraud, Lyons, FR;

Francois Mallet, Villeurbanne, FR;

Assignee:

Biomerieux, Marcy l'Etoile, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); C12P 19/34 (2006.01); C12Q 1/70 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/686 (2013.01); C12Q 7/6886 (2013.01); C12Q 1/702 (2013.01); C12Q 2535/125 (2013.01); C12Q 2600/154 (2013.01);
Abstract

A method for in vitro diagnosis or prognosis of testicular cancer in a biological sample from a patient suspected of suffering from testicular cancer, having a step of detecting the presence or absence of methylation of CpG dinucleotides in at least one genomic DNA target sequence of the sample, the target sequence being selected from at least one of the sequences identified in SEQ ID NOS: 1 to 7 or from at least one sequence which exhibits at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 7 and the sequences complementary thereto; to the DNA sequences and to the use thereof as a testicular cancer marker.


Find Patent Forward Citations

Loading…